SCHEMBL10666152

SCHEMBL10666152

O=[N+]([O-])CCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8767986 0.80
SCHEMBL66347 0.76
SCHEMBL1415089 0.76
SCHEMBL1100249 0.72
SCHEMBL1280829 0.71
SCHEMBL719096 0.69 ALDH1A1 (0.67)
SCHEMBL1011508 0.69
Hydrochloric Acid SCHEMBL8895147 0.69
SCHEMBL17550102 0.67
SCHEMBL1311257 0.67 ALDH1A1 (0.72)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102548954-A Method for producing 2,2-difluoroethylamine by hydrogenating 1,1-difluoro-2-nitroethane BAYER CROPSCIENCE AG 2012-07-04 CN claimed
US-4767864-A Process for the preparation of nitromethylene derivatives BAYER AKTIENGESELLSCHAFT (DE) 1988-08-30 US claimed
CN-116063210-B Method for chiral synthesis of D-p-methylsulfonyl phenylserine ethyl ester 山东国邦药业有限公司 2023-06-27 CN disclosed
CN-116063210-A Method for chiral synthesis of D-p-methylsulfonyl phenylserine ethyl ester 山东国邦药业有限公司 2023-05-05 CN disclosed
CN-109999856-A It is a kind of for synthesizing the catalyst, preparation method and application of 2,2- difluoroethylamine 陕西神光化学工业有限公司 2019-07-12 CN disclosed
CN-109400483-A The production technology of one kind 2,2- difluoroethylamine 南通宝凯化工有限公司 2019-03-01 CN disclosed
US-20180002322-A1 BICYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-01-04 US disclosed
CN-102548954-B Method for producing 2,2-difluoroethylamine by hydrogenating 1,1-difluoro-2-nitroethane BAYER CROPSCIENCE AG 2014-04-16 CN disclosed
US-8329718-B2 N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions BRISTOL-MYERS SQUIBB COMPANY (US) 2012-12-11 US disclosed
CN-102548954-A Method for producing 2,2-difluoroethylamine by hydrogenating 1,1-difluoro-2-nitroethane BAYER CROPSCIENCE AG 2012-07-04 CN disclosed
US-20100197716-A1 N-LINKED HETEROCYCLIC ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS BRISTOL-MYERS SQUIBB COMPANY 2010-08-05 US disclosed
US-7728008-B2 N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions BRISTOL-MYERS SQUIBB COMPANY (US) 2010-06-01 US disclosed
US-7605144-B2 Enzyme catalyzed therapeutic compounds CELMED ONCOLOGY (USA), INC. (CA) 2009-10-20 US disclosed
US-7601703-B2 Enzyme catalyzed therapeutic agents CELMED ONCOLOGY (USA), INC. (CA) 2009-10-13 US disclosed
US-7550499-B2 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions BRISTOL-MYERS SQUIBB COMPANY (US) 2009-06-23 US disclosed
US-7462605-B2 Phosphoramidate compounds and methods of use CELMED ONCOLOGY (USA), INC. (CA) 2008-12-09 US disclosed
US-7419968-B1 Methods for treating therapy-resistant tumors CELMED ONCOLOGY (USA), INC. (CA) 2008-09-02 US disclosed
US-4767864-A Process for the preparation of nitromethylene derivatives BAYER AKTIENGESELLSCHAFT (DE) 1988-08-30 US disclosed
US-4767864-A Process for the preparation of nitromethylene derivatives BAYER AKTIENGESELLSCHAFT (DE) 1988-08-30 US disclosed